This is an observational, prospective, non-randomized, non-significant risk study collecting voice recordings from subjects who are being tested for COVID-19 by laboratory analysis of specimens obtained by nasal or naso-pharyngeal (NP) swab.
Patients record their voices through an app on their mobile phone. Patients and health care providers will be blinded to the swab test results during Phase 2 of the study.
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.
Study type: Observational
Estimated Enrollment: 400 participants
Estimated Study Start Date: June 2020
Estimated Study Completion Date: December 2020
- Presence of tracheostomy or past tracheostomy with permanent change to the voice due complications that involved the vocal cords.
- Prior surgery which may influence the vocal cords, e.g., laryngeal, tracheal or esophageal surgery
- Prior head, neck or throat cancer treated with radical neck dissection and/or radiation therapy that may influence the vocal cords
- Treatment with another investigational drug or device within 30 days prior to signing Consent Form
Patients record their voices through an app on their mobile phone.
Thank you for your interest in advancing COVID-19 treatments.
Please fill out this contact form to be connected to a member of the study team. The following information that you enter will only be authorized to be shared with the research team conducting this specific study.
If you have any difficulties or questions, please contact our support specialists at [email protected]
For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you’ll be connected to the study team.